Welcome to This Week in Rheumatology. This week we're covering 6 notable papers spanning risk stratification in systemic autoimmune diseases and new insights into disease pathophysiology. Let's dive in.
A central challenge in managing systemic rheumatic diseases is predicting and preventing severe complications. This week, several papers offer new tools and insights, particularly for patients wit…
This week's papers:
- Pulmonary arterial hypertension susceptibility and mortality among patients with systemic sclerosis with the DNASE1L3 rs35677470 (Arg206Cys) variant — Annals of the rheumatic diseases 2026
- Prospective evaluation of recombinant Herpes zoster vaccine in systemic sclerosis: immunogenicity, safety, and disease outcomes — Rheumatology (Oxford, England) 2026
- Development and Validation of the ALARN Model: A Predictive Mortality Score for Antisynthetase Syndrome — Arthritis & rheumatology (Hoboken, N.J.) 2026
- Malignancy Rates in children, young people, and adults with Juvenile Inflammatory Arthritis (JIA): an observational study using CPRD Aurum — Rheumatology (Oxford, England) 2026
- GPR15-guided CD8T regulatory cells control intestinal inflammation — Nature 2026
Listen at AudioScholar